Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies
Go back to Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies| Gilead Sciences (NASDAQ: GILD) | Delayed: 150.11 -0.78 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.89 | 52 Week High | $108.63 | |||
| Open | $150.56 | 52 Week Low | $71.39 | |||
| Day High | $153.23 | P/E | 82.93 | |||
| Day Low | $149.57 | EPS | $1.81 | |||
| Volume | 16,453,710 | |||||
| (NYSE: RCUS) | Delayed: 25.24 -0.3 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.54 | 52 Week High | $ | |||
| Open | $25.74 | 52 Week Low | $ | |||
| Day High | $25.74 | P/E | N/A | |||
| Day Low | $25.02 | EPS | $ | |||
| Volume | 2,897,087 | |||||
